18-Gy craniospinal irradiation remains unsupported for unselected standard-risk medulloblastoma
Pooled five-year disease-control survival was 81.0% after 23.4-Gy CSI versus 71.3% after 18 Gy, supporting caution with further dose reduction.
Pooled five-year disease-control survival was 81.0% after 23.4-Gy CSI versus 71.3% after 18 Gy, supporting caution with further dose reduction.
In nine-patient planning comparisons, proton CSI achieved the lowest activity-weighted marrow dose at 10.9 Gy versus 16.2–19.2 Gy with photon techniques.
SMART-BRAIN proton planning spared portions of non-target brain while maintaining target coverage in five medulloblastoma cases.